Skip to main content
Top
Published in: Cancer Causes & Control 7/2009

01-09-2009 | Original Paper

Serum calcium and the risk of prostate cancer

Authors: C. Halthur, A. L. V. Johansson, M. Almquist, J. Malm, H. Grönberg, J. Manjer, P. W. Dickman

Published in: Cancer Causes & Control | Issue 7/2009

Login to get access

Abstract

Background

Recent studies have suggested an association between high dietary intake of calcium and the risk of prostate cancer. Calcium-rich diet has been suggested to affect the serum levels of Vitamin D, and thereby promote cancer. We conducted the largest study of the association between prediagnostic serum levels of calcium and the risk of prostate cancer.

Outline

We examined the incidence of prostate cancer in relation to prediagnostic serum calcium levels in a prospective cohort study of 22,391 healthy Swedish men, of which 1,539 incident cases of prostate cancer were diagnosed during the 30 years of follow-up until December 2006.

Material and methods

Serum levels of calcium were measured at baseline, and categorized into quartiles. Cox regression was used to estimate the adjusted hazard ratios (HR) with 95% confidence intervals (CI).

Results

We found no evidence of an association between prediagnostic serum levels of calcium and risk of prostate cancer (HR for trend = 0.99 [95% CI;0.94–1.03]). However, a moderate significant negative association was seen in men with a BMI above 25 and aged below 45 years at baseline (Highest vs. lowest quartile, HR = 0.63 [95% CI;0.40–0.99]).

Conclusion

These data do not support the hypothesis that high serum calcium levels is a risk factor for prostate cancer. On the contrary, the data suggest that high serum levels of calcium in young overweight men may be a marker for a decreased risk of developing prostate cancer.
Literature
2.
go back to reference Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL (2001) Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study. Am J Clin Nutr 74:549–554PubMed Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL (2001) Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study. Am J Clin Nutr 74:549–554PubMed
3.
go back to reference Tseng M, Breslow RA, Graubard BI, Ziegler RG (2005) Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr 81:1147–1154PubMed Tseng M, Breslow RA, Graubard BI, Ziegler RG (2005) Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr 81:1147–1154PubMed
4.
go back to reference Giovannucci E, Liu Y, Stampfer MJ, Willett WC (2006) A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 15:203–210PubMedCrossRef Giovannucci E, Liu Y, Stampfer MJ, Willett WC (2006) A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 15:203–210PubMedCrossRef
5.
go back to reference Kesse E, Bertrais S, Astorg P, Jaouen A, Arnault N, Galan P et al (2006) Dairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supplémentation en Vitamines et Minéraux Antioxydants) study. Br J Nutr 95:539–545PubMedCrossRef Kesse E, Bertrais S, Astorg P, Jaouen A, Arnault N, Galan P et al (2006) Dairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supplémentation en Vitamines et Minéraux Antioxydants) study. Br J Nutr 95:539–545PubMedCrossRef
6.
go back to reference Gao X, LaValley MP, Tucker KL (2005) Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 97:1768–1777PubMedCrossRef Gao X, LaValley MP, Tucker KL (2005) Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 97:1768–1777PubMedCrossRef
7.
go back to reference Giovannucci E (1998) Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 9:567–582PubMedCrossRef Giovannucci E (1998) Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 9:567–582PubMedCrossRef
8.
go back to reference Schwartz GG, Hulka BS (1990) Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10:1307–1311PubMed Schwartz GG, Hulka BS (1990) Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10:1307–1311PubMed
9.
go back to reference Skinner HG, Schwartz GG (2008) Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 17:2302–2305PubMedCrossRef Skinner HG, Schwartz GG (2008) Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 17:2302–2305PubMedCrossRef
10.
go back to reference Skinner HG, Schwartz GG (2009) A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 18:575–578PubMedCrossRef Skinner HG, Schwartz GG (2009) A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 18:575–578PubMedCrossRef
11.
go back to reference Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M et al (2007) Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 16:2623–2630PubMedCrossRef Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M et al (2007) Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 16:2623–2630PubMedCrossRef
12.
go back to reference Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 64:729–736PubMedCrossRef Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 64:729–736PubMedCrossRef
13.
go back to reference Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519–1524PubMedCrossRef Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519–1524PubMedCrossRef
14.
go back to reference Baron JA, Beach M, Wallace K, Grau MV, Sandler RS, Mandel JS et al (2005) Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 14:586–589PubMedCrossRef Baron JA, Beach M, Wallace K, Grau MV, Sandler RS, Mandel JS et al (2005) Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 14:586–589PubMedCrossRef
15.
go back to reference Bonjour JP, Chevalley T, Fardellone P (2007) Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate cancer. Br J Nutr 97:611–616PubMedCrossRef Bonjour JP, Chevalley T, Fardellone P (2007) Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate cancer. Br J Nutr 97:611–616PubMedCrossRef
16.
go back to reference Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ (1996) Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 5:121–126PubMed Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ (1996) Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 5:121–126PubMed
17.
go back to reference Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11:847–852PubMedCrossRef Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11:847–852PubMedCrossRef
18.
go back to reference Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case–control study in the Nordic countries. Int J Cancer 108:104–108PubMedCrossRef Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case–control study in the Nordic countries. Int J Cancer 108:104–108PubMedCrossRef
19.
go back to reference Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA (2007) Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men. Cancer Epidemiol Biomarkers Prev 16:2784–2786PubMedCrossRef Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA (2007) Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men. Cancer Epidemiol Biomarkers Prev 16:2784–2786PubMedCrossRef
20.
go back to reference Jacobs ET, Giuliano AR, Martńnez ME, Hollis BW, Reid ME, Marshall JR (2004) Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 89–90:533–537 Jacobs ET, Giuliano AR, Martńnez ME, Hollis BW, Reid ME, Marshall JR (2004) Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 89–90:533–537
21.
go back to reference Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15:255–265PubMedCrossRef Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15:255–265PubMedCrossRef
22.
go back to reference Almquist M, Manjer J, Bondeson L, Bondeson AG (2007) Serum calcium and breast cancer risk: results from a prospective cohort study of 7,847 women. Cancer Causes Control 18:595–602PubMedCrossRef Almquist M, Manjer J, Bondeson L, Bondeson AG (2007) Serum calcium and breast cancer risk: results from a prospective cohort study of 7,847 women. Cancer Causes Control 18:595–602PubMedCrossRef
23.
go back to reference Berglund G, Eriksson KF, Israelsson B, Kjellström T, Lindgärde F, Mattiasson I et al (1996) Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project. J Intern Med 239:489–497 (MPP Malmö Preventive Project) Berglund G, Eriksson KF, Israelsson B, Kjellström T, Lindgärde F, Mattiasson I et al (1996) Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project. J Intern Med 239:489–497 (MPP Malmö Preventive Project)
24.
go back to reference Selzer ML (1971) The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127:1653–1658PubMed Selzer ML (1971) The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127:1653–1658PubMed
25.
go back to reference Kristenson H, Trell E (1982) Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. Br J Addict 77:297–304PubMedCrossRef Kristenson H, Trell E (1982) Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. Br J Addict 77:297–304PubMedCrossRef
26.
go back to reference Lindkvist B, Appelros S, Manjer J, Berglund G, Borgstrom A (2008) A prospective cohort study of smoking in acute pancreatitis. Pancreatology 8:63–70PubMedCrossRef Lindkvist B, Appelros S, Manjer J, Berglund G, Borgstrom A (2008) A prospective cohort study of smoking in acute pancreatitis. Pancreatology 8:63–70PubMedCrossRef
28.
go back to reference Barlow L, Westergren K, Holmberg L, Talbäck M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48:27–33PubMedCrossRef Barlow L, Westergren K, Holmberg L, Talbäck M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48:27–33PubMedCrossRef
29.
go back to reference SPSS Version 15.0. SPSS Inc. headquarters, 233 S. Wacker Drive, 11th floor, Chicago, IL 60606 SPSS Version 15.0. SPSS Inc. headquarters, 233 S. Wacker Drive, 11th floor, Chicago, IL 60606
30.
go back to reference SPSS Version 16.0. SPSS Inc. headquarters, 233 S. Wacker Drive, 11th floor, Chicago, IL 60606 SPSS Version 16.0. SPSS Inc. headquarters, 233 S. Wacker Drive, 11th floor, Chicago, IL 60606
31.
go back to reference Bischof MG, Heinze G, Vierhapper H (2006) Vitamin D status and its relation to age and body mass index. Horm Res 66:211–215PubMedCrossRef Bischof MG, Heinze G, Vierhapper H (2006) Vitamin D status and its relation to age and body mass index. Horm Res 66:211–215PubMedCrossRef
32.
go back to reference Prins GS, Korach KS (2008) The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73(3): 233–244PubMedCrossRef Prins GS, Korach KS (2008) The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73(3): 233–244PubMedCrossRef
33.
go back to reference Falahati-Nini A, Riggs BL, Atkinson EJ, O’Fallon WM, Eastell R, Khosla S (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553–1560PubMedCrossRef Falahati-Nini A, Riggs BL, Atkinson EJ, O’Fallon WM, Eastell R, Khosla S (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553–1560PubMedCrossRef
34.
go back to reference Kvåle R, Auvinen A, Adami HO, Klint A, Hernes E, Møller B et al (2007) Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 99:1881–1887PubMedCrossRef Kvåle R, Auvinen A, Adami HO, Klint A, Hernes E, Møller B et al (2007) Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 99:1881–1887PubMedCrossRef
36.
go back to reference OCSyd (2004) Prostatacancer Regional rapport. Technical report, Onkologiskt Centrum Syd, Sweden OCSyd (2004) Prostatacancer Regional rapport. Technical report, Onkologiskt Centrum Syd, Sweden
37.
go back to reference OCsyd (2006) Prostatacancer Regional rapport. Technical report, Onkologiskt Centrum Syd, Sweden OCsyd (2006) Prostatacancer Regional rapport. Technical report, Onkologiskt Centrum Syd, Sweden
38.
go back to reference Nilsson-Ehle P (2003) Laurells klinisk kemi i praktisk medicin. Studentlitteratur AB, Sweden Nilsson-Ehle P (2003) Laurells klinisk kemi i praktisk medicin. Studentlitteratur AB, Sweden
39.
go back to reference Almquist M, Bondeson AG, Bondeson L, Halthur C, Malm J, Manjer J (2008) Reproductive history, lifestyle factors and season as determinants for serum calcium concentrations in women. Scand J Clin Lab Invest 68:777–785PubMedCrossRef Almquist M, Bondeson AG, Bondeson L, Halthur C, Malm J, Manjer J (2008) Reproductive history, lifestyle factors and season as determinants for serum calcium concentrations in women. Scand J Clin Lab Invest 68:777–785PubMedCrossRef
40.
go back to reference Leifsson BG, Ahrén B (1996) Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 81:2149–2153PubMedCrossRef Leifsson BG, Ahrén B (1996) Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 81:2149–2153PubMedCrossRef
41.
go back to reference Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H et al (2000) Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med 247:19–29PubMedCrossRef Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H et al (2000) Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med 247:19–29PubMedCrossRef
42.
go back to reference Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132:2208–2225PubMedCrossRef Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132:2208–2225PubMedCrossRef
Metadata
Title
Serum calcium and the risk of prostate cancer
Authors
C. Halthur
A. L. V. Johansson
M. Almquist
J. Malm
H. Grönberg
J. Manjer
P. W. Dickman
Publication date
01-09-2009
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 7/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9342-y

Other articles of this Issue 7/2009

Cancer Causes & Control 7/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine